TELO - Telomir Pharmaceuticals, Inc. Quarterly EPS earnings growth

Public company logo of Telomir Pharmaceuticals, Inc. (TELO)

The quarterly EPS evolution metric on this GURU.Markets platform chart demonstrates profit dynamics, where the value 70.50 represents the most recent figure. Telomir Pharmaceuticals (TELO) ensures supply security through strictly controlled logistics. The company implements green chemistry and bioethics principles in its production. The business currently relies on scientific grants, as commercial products are still in the laboratory stage.

Telomir Pharmaceuticals Inc (TELO) Year-over-year earnings per one share growth for the last 12 months: for the period 02/21/2024 - 11/17/2026

Analytical breakdowns for Telomir Pharmaceuticals

- share price and expert price forecast:
Fundamental valuation:Telomir Pharmaceuticals
Flagship merchandise of Telomir Pharmaceuticals

Given the extreme scientific risks associated with Telomir Pharmaceuticals (TELO), where a failure to commercialize research could wipe out capital, monitoring real business efficiency becomes critical. By analyzing the quarterly EPS growth rate, an investor tracks the dynamics of net profit per share, which allows for the timely identification of fading expansion drivers and prevents the purchase of overvalued assets within the high-risk biotechnology sector.

Analysis of competing companies

HLN: Quarterly EPS earnings growth|Kenvue Corp - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma PLC) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months jyongbio.com MENS|Year-over-year earnings per share growth for the last twelve months Ligand (LGND)|AMRX (Amneal) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Perrigo PRGO|Quarterly EPS earnings growth Alvotech Biopharmaceuticals ALVO|liquidia.com - Quarterly EPS earnings growth|GLPG - Quarterly EPS earnings growth|ANIP: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months MNKD|AMPH (Amphastar) - Quarterly EPS earnings growth|Pacira Corp (PCRX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months ARS Pharma (SPRY)|Quarterly EPS earnings growth Theravance Biopharma, Inc. (TBPH)|Aquestive Therapeutics - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SCPH|Tectonic Therapeutic Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TNXP|SXTC (China SXT Pharmaceuticals) - Year-over-year net earnings per share growth for the last 12 months|Eupraxia Pharmaceuticals (EPRX) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months BioHarvest Sciences, Inc.|EXOZ: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ORMP|ENTX - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months MindWalk Holdings, Inc. HYFT|Quarterly EPS earnings growth abvcpharma.com ABVC|CPIX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months QNTM|FGEN (FibroGen Corporation) - Year-over-year net earnings per share growth for the last 12 months|Rani Therapeutics (RANI) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Synergy CHC Corp.|Earnings per share growth in annualized terms for the last twelve months rallybio.com RLYB|Quarterly EPS earnings growth LEXX|PULM: Year-over-year net earnings per share trend for the last twelve months|Pheton Holdings Ltd - Year-over-year net earnings per share growth for the last 12 months|APM - Year-over-year net earnings per share growth for the last 12 months|LYRA - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months IBO (Impact BioMedical)|TNF Pharmaceuticals Inc. (TNFA) - Year-over-year earnings per share growth for the last twelve months|cbdMD Corp - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months PRFX|Altamira Therapeutics (CYTO) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth LIPO|Quarterly EPS earnings growth optinose.com (OPTN)|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals, Inc. PIRS|Procaps (PROC) - Earnings per share growth in annualized terms for the last twelve months|PTPI - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Qilian International Corp QLI|SLRN: Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TFFP (tffpharma.com)